![Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents | Anales de Pediatría Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents | Anales de Pediatría](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2341287919300079:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qVHBXBqbSQ7FNUvNof+6+l4v03CmyaR9Rm+q8TRfDEOS68CZK9bYY3KxU3zGztav7fGv8jR71hLVrmCMOFHZD2bGkuDFYqrbKCqeAmGMQ4UfsdfyvWy28MoJZpirLnRKylskjROw1fvHUoqsF3VzjfNnRVLuWpSM8pmy4pQDh3Q0IC6jiKC23VEpUaYzPUgKYxdUrSOLLkhjJeURZlHKVSV9ZeHy1g8pO5wt6Ta9459Rp2dIGXO2KL/h1wUY6wohJPIwQPfV6Xfv205PKDZRk=)
Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents | Anales de Pediatría
![Pegylated Interferon Maintenance Therapy for Recurrent Hepatitis C after Liver Transplantation - ATC Abstracts Pegylated Interferon Maintenance Therapy for Recurrent Hepatitis C after Liver Transplantation - ATC Abstracts](https://atcmeetingabstracts.com/wp-content/uploads/2013/04/1326.jpg)
Pegylated Interferon Maintenance Therapy for Recurrent Hepatitis C after Liver Transplantation - ATC Abstracts
![Addition of pentoxifylline to pegylated interferon alpha 2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial Addition of pentoxifylline to pegylated interferon alpha 2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial](https://data02.123dok.com/thumb/8y/d1/0jly/Pki4ZiPT5VIqTD1so/cover.webp)
Addition of pentoxifylline to pegylated interferon alpha 2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial
![A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjects. | Semantic Scholar A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjects. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4631d089fcc06f213a9ac9615d914c49a7e03f57/18-Figure2-1.png)
A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjects. | Semantic Scholar
![IJERPH | Free Full-Text | A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B | HTML IJERPH | Free Full-Text | A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B | HTML](https://www.mdpi.com/ijerph/ijerph-13-00730/article_deploy/html/images/ijerph-13-00730-g001.png)
IJERPH | Free Full-Text | A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B | HTML
![Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV) | SpringerLink Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV) | SpringerLink](https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs40164-017-0090-5/MediaObjects/40164_2017_90_Fig1_HTML.jpg)